98 related articles for article (PubMed ID: 21427993)
1. [Peyronie's disease: comparative results of conservative treatment].
Kovalev VA; Karaguzhin SK; Abdulkhamidov AN; Danovich VM; Kyzlasov PS; Matskevich SV
Urologiia; 2010; (6):40-4. PubMed ID: 21427993
[TBL] [Abstract][Full Text] [Related]
2. Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results.
Montorsi F; Salonia A; Guazzoni G; Barbieri L; Colombo R; Brausi M; Scattoni V; Rigatti P; Pizzini G
J Androl; 2000; 21(1):85-90. PubMed ID: 10670523
[TBL] [Abstract][Full Text] [Related]
3. Medical management of Peyronie's disease.
Hellstrom WJ
J Androl; 2009; 30(4):397-405. PubMed ID: 18974422
[TBL] [Abstract][Full Text] [Related]
4. Systemic corticosteroid treatment in Peyronie's disease.
Uzun H
Med Hypotheses; 2013 Dec; 81(6):1029-30. PubMed ID: 24119766
[TBL] [Abstract][Full Text] [Related]
5. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.
Lacy GL; Adams DM; Hellstrom WJ
Int J Impot Res; 2002 Oct; 14(5):336-9. PubMed ID: 12454683
[TBL] [Abstract][Full Text] [Related]
6. Intralesional injection therapy for Peyronie's disease.
Hellstrom WJ; Cockerham YR
J Sex Med; 2009 Jul; 6(7):1811-4. PubMed ID: 19575773
[No Abstract] [Full Text] [Related]
7. Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
Di Stasi SM; Giannantoni A; Capelli G; Jannini EA; Virgili G; Storti L; Vespasiani G
BJU Int; 2003 Jun; 91(9):825-9. PubMed ID: 12780842
[TBL] [Abstract][Full Text] [Related]
8. Peyronie's Disease: Overview and Recent Treatment Advances.
Pires J; Travis M; Ellsworth P
Urol Nurs; 2015; 35(4):164-78. PubMed ID: 26402991
[TBL] [Abstract][Full Text] [Related]
9. Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease. Our experience.
Garrido Abad P; Coloma A; Herranz LM; Jiménez M; Suárez C; Prieto MD; Formoso T; Fernández Arjona M
Arch Esp Urol; 2012 Oct; 65(8):745-51. PubMed ID: 23117682
[TBL] [Abstract][Full Text] [Related]
10. [Conservative treatment of Peyronie's disease in the light of new pathogenetic data].
Mazo EB; Mufaged ML; Ivanchenko LP; Kalashnikova EA; Terekhov SM
Urologiia; 2006; (2):32-5, 37. PubMed ID: 16708586
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Peyronie's disease with local interferon-alpha 2b.
Brake M; Loertzer H; Horsch R; Keller H
BJU Int; 2001 May; 87(7):654-7. PubMed ID: 11350406
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
Di Stasi SM; Giannantoni A; Stephen RL; Capelli G; Giurioli A; Jannini EA; Vespasiani G
J Urol; 2004 Apr; 171(4):1605-8. PubMed ID: 15017231
[TBL] [Abstract][Full Text] [Related]
13. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease.
Mehrsai AR; Namdari F; Salavati A; Dehghani S; Allameh F; Pourmand G
Andrology; 2013 Jan; 1(1):129-32. PubMed ID: 23258641
[TBL] [Abstract][Full Text] [Related]
15. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
[TBL] [Abstract][Full Text] [Related]
16. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
Fitch WP; Easterling WJ; Talbert RL; Bordovsky MJ; Mosier M
J Sex Med; 2007 Mar; 4(2):477-84. PubMed ID: 17367443
[TBL] [Abstract][Full Text] [Related]
17. [Clinical effects of verapamil in the treatment of Peyronie's disease].
Arena F; Peracchia G; Di Stefano C; Passari A; Larosa M; Cortellini P
Acta Biomed Ateneo Parmense; 1995; 66(6):269-72. PubMed ID: 8928594
[TBL] [Abstract][Full Text] [Related]
18. Peyronie's disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging.
Polat O; Gül O; Ozbey I; Ozdikici M; Bayraktar Y
Int Urol Nephrol; 1997; 29(4):465-71. PubMed ID: 9406006
[TBL] [Abstract][Full Text] [Related]
19. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
Cavallini G; Modenini F; Vitali G
Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
[TBL] [Abstract][Full Text] [Related]
20. Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease.
Russell S; Steers W; McVary KT
Eur Urol; 2007 Mar; 51(3):640-7. PubMed ID: 17092631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
